scholarly journals Postprandial renal hemodynamic effects of DPP ‐4 inhibitor linagliptin versus sulfonylurea glimepiride in adults with type 2 diabetes ( RENALIS ): a pre‐defined sub‐study of a randomized, double‐blind trial

2021 ◽  
Author(s):  
Marcel H.A. Muskiet ◽  
Lennart Tonneijck ◽  
Mark M. Smits ◽  
Mark H.H. Kramer ◽  
D. Margriet Ouwens ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Double Blind Trial ◽  
Hemodynamic Effects ◽  
Double Blind ◽  
Blind Trial ◽  
Renal Hemodynamic

Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial

The Lancet ◽  
2015 ◽  
Vol 385 (9982) ◽  
pp. 2067-2076 ◽  
Author(s):  
Faiez Zannad ◽  
Christopher P Cannon ◽  
William C Cushman ◽  
George L Bakris ◽  
Venu Menon ◽  
...  
Keyword(s):  
Heart Failure ◽  
Type 2 Diabetes ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial

The Lancet ◽  
2017 ◽  
Vol 389 (10077) ◽  
pp. 1399-1409 ◽  
Author(s):  
Carel W le Roux ◽  
Arne Astrup ◽  
Ken Fujioka ◽  
Frank Greenway ◽  
David C W Lau ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Risk Reduction ◽  
Weight Management ◽  
Diabetes Risk ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals Metabolic Effects of Replacing Sucrose by Isomaltulose in Subjects With Type 2 Diabetes: A randomized double-blind trial

Diabetes Care ◽  
2012 ◽  
Vol 35 (6) ◽  
pp. 1249-1251 ◽  
Author(s):  
S. Brunner ◽  
I. Holub ◽  
S. Theis ◽  
A. Gostner ◽  
R. Melcher ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Metabolic Effects ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial

scholarly journals Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial

BMJ ◽  
2009 ◽  
Vol 339 (nov09 1) ◽  
pp. b4324-b4324 ◽  
Author(s):  
S. S Lund ◽  
L. Tarnow ◽  
M. Frandsen ◽  
B. B Nielsen ◽  
B. V Hansen ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Obese Patients ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial ◽  
Insulin Secretagogue

Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial

The Lancet ◽  
2019 ◽  
Vol 394 (10208) ◽  
pp. 1519-1529 ◽  
Author(s):  
David R Matthews ◽  
Päivi M Paldánius ◽  
Pieter Proot ◽  
YannTong Chiang ◽  
Michael Stumvoll ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Combination Therapy ◽  
Double Blind Trial ◽  
Newly Diagnosed ◽  
Double Blind ◽  
Blind Trial ◽  
Metformin Monotherapy ◽  
Early Combination Therapy

Efficacy and safety of exenatide as add‐on therapy for patients with type 2 diabetes with an intensive insulin regimen: A randomized double‐blind trial

2020 ◽  
Author(s):  
Michael Joubert ◽  
Victoria Opigez ◽  
Barbora Pavlikova ◽  
Laure Peyro Saint Paul ◽  
Nathalie Jeandidier ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Insulin Regimen ◽  
Double Blind Trial ◽  
Efficacy And Safety ◽  
Double Blind ◽  
Blind Trial

Addition of Mitiglinide to Pioglitazone Monotherapy Improves Overall Glycemic Control in Japanese Patients with Type 2 Diabetes: A Randomized Double Blind Trial

2009 ◽  
Vol 56 (5) ◽  
pp. 657-664 ◽  
Author(s):  
Kohei KAKU ◽  
Shun-ichi TANAKA ◽  
Hideki ORIGASA ◽  
Masatoshi KIKUCHI ◽  
Yasuo AKANUMA
Keyword(s):  
Type 2 Diabetes ◽  
Glycemic Control ◽  
Japanese Patients ◽  
Double Blind Trial ◽  
Double Blind ◽  
Blind Trial
Sign in / Sign up

Export Citation Format

Share Document